Advertisement

Research Article Free access | 10.1172/JCI112912

Suppression of anti-DNA antibody synthesis in vitro by a cross-reactive antiidiotypic antibody.

A Epstein, M Greenberg, B Diamond, and A I Grayzel

Find articles by Epstein, A. in: JCI | PubMed | Google Scholar

Find articles by Greenberg, M. in: JCI | PubMed | Google Scholar

Find articles by Diamond, B. in: JCI | PubMed | Google Scholar

Find articles by Grayzel, A. in: JCI | PubMed | Google Scholar

Published March 1, 1987 - More info

Published in Volume 79, Issue 3 on March 1, 1987
J Clin Invest. 1987;79(3):997–1000. https://doi.org/10.1172/JCI112912.
© 1987 The American Society for Clinical Investigation
Published March 1, 1987 - Version history
View PDF
Abstract

An understanding of the regulatory mechanisms that govern the humoral immune response will be facilitated by the availability of techniques for the measurement of specific antibody production in vitro. We have developed an enzyme-linked immunosorbent assay system for the measurement of in vitro anti-DNA antibody production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus. Using this technique, the PBMC from 74% of serologically active SLE patients produced levels of anti-DNA antibodies that were greater than 2 SD above the mean of 18 +/- 9 IU/ml for normal subjects. Furthermore, the addition of 3I, a monoclonal anti-idiotypic antibody that recognizes a cross-reactive determinant on anti-DNA antibodies, was shown to specifically inhibit anti-DNA production in vitro.

Browse pages

Click on an image below to see the page. View PDF of the complete article

Version history
  • Version 1 (March 1, 1987): No description
Advertisement
Advertisement